Cargando…
Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia
As effective therapies for relapse and refractory B-cell acute lymphoblastic leukemia (B-ALL) remain problematic, novel therapeutic strategies are needed. Artemis is a key endonuclease in V(D)J recombination and nonhomologous end joining (NHEJ) of DNA double-strand break (DSB) repair. Inhibition of...
Autores principales: | Ogana, Heather A., Hurwitz, Samantha, Hsieh, Chih-Lin, Geng, Huimin, Müschen, Markus, Bhojwani, Deepa, Wolf, Mark A., Larocque, James, Lieber, Michael R., Kim, Yong Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111164/ https://www.ncbi.nlm.nih.gov/pubmed/37082620 http://dx.doi.org/10.3389/fcell.2023.1134121 |
Ejemplares similares
-
Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia
por: Ruan, Yongsheng, et al.
Publicado: (2021) -
Structure-Specific nuclease activities of Artemis and the Artemis: DNA-PKcs complex
por: Chang, Howard H.Y., et al.
Publicado: (2016) -
In vitro and in vivo effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA-4, in B-cell acute lymphoblastic leukemia
por: Ruan, Yongsheng, et al.
Publicado: (2022) -
Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
por: Mezzatesta, Caterina, et al.
Publicado: (2019) -
Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia
por: Raboso-Gallego, Javier, et al.
Publicado: (2019)